RxDoctor Payments Data

Michael Barrett, MD

Family Medicine · Lamar, SCNPI 1588637771

Payments from drug & device makers

$2,759in general payments, 2019–2025

Across 148 payments — averaging $18.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$381
  • Astellas Pharma US Inc$358
  • Novo Nordisk$284
  • Amgen$274
  • AstraZeneca$238
  • Esperion Therapeutics, Inc.$211
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,759100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,759 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$64,472
Medicare patients
191
Services billed
7,240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate156$217,133
LipitorAtorvastatin Calcium86$119,928
WelcholColesevelam Hcl84$102,967
FarxigaDapagliflozin Propanediol80$99,664
OzempicSemaglutide77$91,718
EliquisApixaban191$85,968
MounjaroTirzepatide66$73,021
NorvascAmlodipine Besylate67$48,829
TradjentaLinagliptin40$48,208
DiovanValsartan43$43,555
NeurontinGabapentin41$42,291
ProtonixPantoprazole Sodium34$40,237
MyrbetriqMirabegron73$38,783
NexletolBempedoic Acid41$32,071
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$31,710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerLipitor, Eliquis, Protonix, Lyrica, Celebrex$72$283,631348 claims
AstraZenecaFarxiga, Crestor, Nexium, Breztri Aerosphere$238$144,925141 claims
Novo NordiskOzempic$284$91,71877 claims
Lilly USA, LLCMounjaro, Cymbalta$201$82,25679 claims
Boehringer IngelheimTradjenta, Jardiance, Flomax$108$80,47572 claims
NovartisDiovan, Entresto$381$61,25859 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy$54$44,66277 claims
Astellas Pharma US IncMyrbetriq$358$38,78373 claims
Esperion Therapeutics, Inc.Nexletol$211$32,07141 claims
AbbVieLinzess, Lexapro$42$26,25733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lamar

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →